HRSA audits found terminations were required for a 340B provider site and a contract pharmacy and that another provider owed repayments to drugmakers.
Three Terminations, 10 Paybacks to Manufacturers in HRSA’s 2023 Pending Provider Audits
Three provider organizations may have contract pharmacies terminated from the 340B program and 10 providers would owe repayments to drug [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.